Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:53 UTC |
---|
HMDB ID | HMDB0015180 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Lubiprostone |
---|
Description | Lubiprostone is a medication used in the management of idiopathic chronic constipation. It is a bicyclic fatty acid (prostaglandin E1 derivative) which acts by specifically activating ClC-2 chloride channels on the apical aspect of gastrointestinal epithelial cells, producing a chloride-rich fluid secretion. These secretions soften the stool, increase motility, and promote spontaneous bowel movements (SBM). |
---|
Structure | [H][C@@]12CC(=O)[C@@H](CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC InChI=1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15+,17+,20+/m0/s1 |
---|
Synonyms | Value | Source |
---|
Amitiza | Kegg | RU-0211 | HMDB | 0211, SPI | HMDB | Lubiprostone | KEGG | 7-[(2R,4AR,5S,7ar)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-octahydrocyclopenta[b]pyran-5-yl]heptanoate | Generator |
|
---|
Chemical Formula | C20H32F2O5 |
---|
Average Molecular Weight | 390.4619 |
---|
Monoisotopic Molecular Weight | 390.221780544 |
---|
IUPAC Name | 7-[(2R,4aR,5S,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-octahydrocyclopenta[b]pyran-5-yl]heptanoic acid |
---|
Traditional Name | lubiprostone |
---|
CAS Registry Number | 136790-76-6 |
---|
SMILES | [H][C@@]12CC(=O)[C@@H](CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC |
---|
InChI Identifier | InChI=1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15+,17+,20+/m0/s1 |
---|
InChI Key | WGFOBBZOWHGYQH-DKYLXPRQSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Eicosanoids |
---|
Direct Parent | Prostaglandins and related compounds |
---|
Alternative Parents | |
---|
Substituents | - Prostaglandin skeleton
- Medium-chain fatty acid
- Halogenated fatty acid
- Heterocyclic fatty acid
- Hydroxy fatty acid
- Oxane
- Fatty acid
- Fluorohydrin
- Halohydrin
- Hemiacetal
- Ketone
- Cyclic ketone
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Oxacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Organohalogen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Alkyl halide
- Alkyl fluoride
- Organic oxygen compound
- Organofluoride
- Organooxygen compound
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.026 g/L | Not Available | LogP | 4.3 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Lubiprostone,1TMS,isomer #1 | CCCCC(F)(F)[C@@]1(O)CC[C@@H]2[C@H](CCCCCCC(=O)O[Si](C)(C)C)C(=O)C[C@H]2O1 | 2625.2 | Semi standard non polar | 33892256 | Lubiprostone,1TMS,isomer #2 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@@H]2[C@H](CCCCCCC(=O)O)C(=O)C[C@H]2O1 | 2672.4 | Semi standard non polar | 33892256 | Lubiprostone,1TMS,isomer #3 | CCCCC(F)(F)[C@@]1(O)CC[C@@H]2C(CCCCCCC(=O)O)=C(O[Si](C)(C)C)C[C@H]2O1 | 2681.9 | Semi standard non polar | 33892256 | Lubiprostone,1TMS,isomer #4 | CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C)[C@H]2CCCCCCC(=O)O)O1 | 2615.4 | Semi standard non polar | 33892256 | Lubiprostone,2TMS,isomer #1 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@@H]2[C@H](CCCCCCC(=O)O[Si](C)(C)C)C(=O)C[C@H]2O1 | 2682.4 | Semi standard non polar | 33892256 | Lubiprostone,2TMS,isomer #2 | CCCCC(F)(F)[C@@]1(O)CC[C@@H]2C(CCCCCCC(=O)O[Si](C)(C)C)=C(O[Si](C)(C)C)C[C@H]2O1 | 2694.0 | Semi standard non polar | 33892256 | Lubiprostone,2TMS,isomer #3 | CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C)[C@H]2CCCCCCC(=O)O[Si](C)(C)C)O1 | 2679.0 | Semi standard non polar | 33892256 | Lubiprostone,2TMS,isomer #4 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@@H]2C(CCCCCCC(=O)O)=C(O[Si](C)(C)C)C[C@H]2O1 | 2743.4 | Semi standard non polar | 33892256 | Lubiprostone,2TMS,isomer #5 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C)[C@H]2CCCCCCC(=O)O)O1 | 2679.7 | Semi standard non polar | 33892256 | Lubiprostone,3TMS,isomer #1 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@@H]2C(CCCCCCC(=O)O[Si](C)(C)C)=C(O[Si](C)(C)C)C[C@H]2O1 | 2736.0 | Semi standard non polar | 33892256 | Lubiprostone,3TMS,isomer #1 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@@H]2C(CCCCCCC(=O)O[Si](C)(C)C)=C(O[Si](C)(C)C)C[C@H]2O1 | 2843.1 | Standard non polar | 33892256 | Lubiprostone,3TMS,isomer #1 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@@H]2C(CCCCCCC(=O)O[Si](C)(C)C)=C(O[Si](C)(C)C)C[C@H]2O1 | 2874.2 | Standard polar | 33892256 | Lubiprostone,3TMS,isomer #2 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C)[C@H]2CCCCCCC(=O)O[Si](C)(C)C)O1 | 2728.7 | Semi standard non polar | 33892256 | Lubiprostone,3TMS,isomer #2 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C)[C@H]2CCCCCCC(=O)O[Si](C)(C)C)O1 | 2781.2 | Standard non polar | 33892256 | Lubiprostone,3TMS,isomer #2 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C)[C@H]2CCCCCCC(=O)O[Si](C)(C)C)O1 | 2897.3 | Standard polar | 33892256 | Lubiprostone,1TBDMS,isomer #1 | CCCCC(F)(F)[C@@]1(O)CC[C@@H]2[C@H](CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)C[C@H]2O1 | 2863.8 | Semi standard non polar | 33892256 | Lubiprostone,1TBDMS,isomer #2 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@@H]2[C@H](CCCCCCC(=O)O)C(=O)C[C@H]2O1 | 2897.6 | Semi standard non polar | 33892256 | Lubiprostone,1TBDMS,isomer #3 | CCCCC(F)(F)[C@@]1(O)CC[C@@H]2C(CCCCCCC(=O)O)=C(O[Si](C)(C)C(C)(C)C)C[C@H]2O1 | 2896.1 | Semi standard non polar | 33892256 | Lubiprostone,1TBDMS,isomer #4 | CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C(C)(C)C)[C@H]2CCCCCCC(=O)O)O1 | 2838.7 | Semi standard non polar | 33892256 | Lubiprostone,2TBDMS,isomer #1 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@@H]2[C@H](CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)C[C@H]2O1 | 3163.5 | Semi standard non polar | 33892256 | Lubiprostone,2TBDMS,isomer #2 | CCCCC(F)(F)[C@@]1(O)CC[C@@H]2C(CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C[C@H]2O1 | 3146.3 | Semi standard non polar | 33892256 | Lubiprostone,2TBDMS,isomer #3 | CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C(C)(C)C)[C@H]2CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O1 | 3137.0 | Semi standard non polar | 33892256 | Lubiprostone,2TBDMS,isomer #4 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@@H]2C(CCCCCCC(=O)O)=C(O[Si](C)(C)C(C)(C)C)C[C@H]2O1 | 3176.5 | Semi standard non polar | 33892256 | Lubiprostone,2TBDMS,isomer #5 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C(C)(C)C)[C@H]2CCCCCCC(=O)O)O1 | 3137.6 | Semi standard non polar | 33892256 | Lubiprostone,3TBDMS,isomer #1 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@@H]2C(CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C[C@H]2O1 | 3407.7 | Semi standard non polar | 33892256 | Lubiprostone,3TBDMS,isomer #1 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@@H]2C(CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C[C@H]2O1 | 3278.1 | Standard non polar | 33892256 | Lubiprostone,3TBDMS,isomer #1 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@@H]2C(CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C[C@H]2O1 | 3119.2 | Standard polar | 33892256 | Lubiprostone,3TBDMS,isomer #2 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C(C)(C)C)[C@H]2CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O1 | 3398.9 | Semi standard non polar | 33892256 | Lubiprostone,3TBDMS,isomer #2 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C(C)(C)C)[C@H]2CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O1 | 3120.6 | Standard non polar | 33892256 | Lubiprostone,3TBDMS,isomer #2 | CCCCC(F)(F)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H](C=C(O[Si](C)(C)C(C)(C)C)[C@H]2CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O1 | 3109.9 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Lubiprostone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4l-5294000000-b83d3a55a0ca5eba6c03 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lubiprostone GC-MS (2 TMS) - 70eV, Positive | splash10-06di-9647460000-b581533fe4735515641f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lubiprostone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lubiprostone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 10V, Positive-QTOF | splash10-05fr-0392000000-baf7c2f7194ed88b0807 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 20V, Positive-QTOF | splash10-05fr-1893000000-05146ad09171774b81e0 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 40V, Positive-QTOF | splash10-07vl-9300000000-1a9036825efee41873b9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 10V, Negative-QTOF | splash10-000i-0098000000-cf19376ddba1a5e460da | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 20V, Negative-QTOF | splash10-007a-1259000000-85786687d62231129447 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 40V, Negative-QTOF | splash10-0a4i-7890000000-6c74f2fbdce947cdac53 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 10V, Positive-QTOF | splash10-05fr-0009000000-35b5046ad072d78455ad | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 20V, Positive-QTOF | splash10-0avm-2039000000-2b4a8e65036c57034fc4 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 40V, Positive-QTOF | splash10-0aor-9520000000-990c2c5e8a719726e6c9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 10V, Negative-QTOF | splash10-000i-0009000000-a5d6e24227bc8251fbe7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 20V, Negative-QTOF | splash10-000i-0029000000-bb4185547119f78da3db | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lubiprostone 40V, Negative-QTOF | splash10-00kr-0193000000-9320001baca5e457ccf2 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Lacy BE, Chey WD: Lubiprostone: chronic constipation and irritable bowel syndrome with constipation. Expert Opin Pharmacother. 2009 Jan;10(1):143-52. doi: 10.1517/14656560802631319 . [PubMed:19236188 ]
- Lacy BE, Levy LC: Lubiprostone: a novel treatment for chronic constipation. Clin Interv Aging. 2008;3(2):357-64. [PubMed:18686757 ]
- Crowell MD, Harris LA, DiBaise JK, Olden KW: Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation. Curr Opin Investig Drugs. 2007 Jan;8(1):66-70. [PubMed:17263187 ]
- Ambizas EM, Ginzburg R: Lubiprostone: a chloride channel activator for treatment of chronic constipation. Ann Pharmacother. 2007 Jun;41(6):957-64. Epub 2007 May 22. [PubMed:17519292 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|